Paul Campanelli

Filings by Paul Campanelli span 2 companies, the busiest being PAR Pharmaceutical Companies, Inc. and Endo International plc. In total, 193 filings cover trades dated from 18 November 2001 to 6 April 2021.

Both buying and selling appear: 6 purchases worth €379k, against 114 sales worth €4.6M. Netting one side against the other leaves €4.2M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 62 share grants and 10 option exercises.

Half of the purchases are above €35k and half below. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 6 April 2021: an option exercise, in Endo International plc. The clock since the last published purchase (15 August 2017) now reads 3,357 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.